Published on 25 May 2024 on The Motley Fool
The stock market has performed relatively well since the beginning of the year although, of course, there is no guarantee that it will maintain that...
Start tracking your investments with Statfolio
FILES-CANADA-HEALTH-VIRUS-VACCINES Everyone loves a comeback story: the underdog fighting back fo...
Amidst a backdrop of mixed performances across global markets, France's CAC 40 Index saw a modest...
Shares of Insmed INSM more than doubled in market value on Tuesday after reporting positive topli...
Johnson & Johnson JNJ announced a definitive agreement with Swiss biotech Numab Therapeutics to a...
In recent trading sessions, France's CAC 40 Index has experienced a modest decline of 0.89%, refl...
Sanofi SNY announced that the FDA has accepted the supplemental biologics license application (sB...
The stock market has performed relatively well since the beginning of the year although, of cours...
Novavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine...
Novavax (NASDAQ:NVAX) stock investors are celebrating on Friday as the vaccine company’s shares h...
(Reuters) -Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with...